1Elder Jr,Fischer G J,Zhang QY,et al.Retinoic acid gene receptor expression in human skin[J].J Invest Dermatol,1991,96(4):425-433.
2Gollnick H,Bauer R,Brindley C,et al.Acitretin versus etretinate in psoriasis:Clinical and pharmacokinetic results of a German Multicenter study[J].J Am Acad Dermatol,1988,19(3):458-469.
3Ozawa A,Ohkido M,Haruki Y,et al.Treatment of generalizad pustular psoriasis:A multicenter study in Japan[J].J Dermatol,1999,26(3):141-149.
4Menter A.Pharmacokinetics and safety of tazarotene[J].J Am Acad Dermatol,2000,43(2 Pt 3):31-35.
5Lebwohl M,Ast E,Callen JP,et al.Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis[J].J Am Acad Dermatol,1998,38(5 Pt1):705-711.
6Tzung TY,Wu JC,Hsu NJ,et al.Comparison of tazarotene0.1% gel plus petrolatum once daily versus calcipotriol 0.005%ointment twice daily in the treatment of plaque psoriasis[J].Acta Derm Venereol,2005,85(3):236-239.
7Martine C.Retinoid therapy for acne[J].Am J Clin Dermatol,2005,6(1):13-19.
8Lehucher-Ceyrac D,Weber-Buisset MJ.Isotretinoin and ache in practice:A prospective analysis of 188 cases over 9 years[J].Dermatology,1993,186(2):81-82.
9Michel S,Jomard A,Demarchez M.Pharmacology of adapalene[J].Br J Dermatol,1998,139(Suppl 52):3-7.
10Leyden JJ.Topical treatment of acne vulgaris:Retinoids and cutaneous irritation[J].J Am Acad Dermatol,1998,38(4):S1-S4.
